Acquisition of CD80 (B7-1) by T cells

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2505-2513

  Sabzevari, H ^a   Kantor, J ^a   Jaigirdar, A ^a   Tagaya, Y ^a   Naramura, M ^a   Hodge, J W ^a   Bernon, J ^a   Schlom, J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CYCLOHEXIMIDE; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOREGULATION; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035865391     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2505     Document Type: Article

References (38)

1. The B7 and CD28 receptor families
2. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
3. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
4. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation
5. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
6. B7/BB.1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro
7. Functional expression of B7/BB.1 on activated T lymphocytes
8. The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T-T cell interactions
9. Discordant expression of CD28 ligands, BB.1 and B7 on keratinocytes in vitro, and psoriatic cells in vivo
10. T cells as antigen-presenting cells
11. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells
12. CD80 and CD86 costimulatory molecules on circulating T cells of HIV-infected individuals
13. + T cells
14. The expression of LFA-1, ICAM-1. CD80 and CD86 molecules in lupus patients: Implications for immunotherapy
15. Reciprocal expression of costimulatory molecules B7.1 and B7.2 on murine T cells following activation
16. Upregulation of Fas and costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/GLD mice
17. Ectopic expression of B7-1 (CD80) on T lymphocytes in autoimmune lpr and gld mice
18. 1-A antigens on cloned alloreactive murine T lymphocytes are acquired passively
19. TCR-mediated internalization of peptide-MHC complexes acquired by T cells
20. - murine thymocytes: Passive acquisition of CD8 accessory molecules
21. T cells can use either T-cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells
22. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
23. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor cell vaccines
24. A triad of costimulatory molecules synergize to amplify T-cell activation
25. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7.1 or B7.2 co-stimulatory molecules
26. B7.1 and B7.2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation
27. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-α
28. Mice with a fluorescent marker for interleukin-2 gene activation
29. Three-dimensional segregation of supramolecular activation clusters in T cells
30. A receptor/cytoskeletal movement triggered by costimulation during T-cell activation
31. T lymphocyte costimulation mediated by reorganization of membrane microdomains
32. The immunological synapse: A molecular machine controlling T cell activation
33. Truncation of the A α chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells
34. Changes in the strength of costimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands
35. The majority of"natural" immunoglobulin secreting cells are short-lived and the progeny of cycling lymphocytes
36. Receptor-stimulated death pathway is opened in antigen in mature T cells
37. Control of CD4 effector fate: Transforming growth factor β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
38. Professional presentation of antigen by activated human T cells